| 注册
首页|期刊导航|国际医药卫生导报|影响重症肺炎患者伏立康唑血药浓度相关因素分析

影响重症肺炎患者伏立康唑血药浓度相关因素分析

麦瑞珊 孟冬梅 谢白露 肖翔林 黄思琪 蔡秀琴 冯凤玉 李曜楷 陈文瑛

国际医药卫生导报2013,Vol.19Issue(24):3687-3690,4.
国际医药卫生导报2013,Vol.19Issue(24):3687-3690,4.DOI:10.3760/cma.j.issn.1007-1245.2013.24.003

影响重症肺炎患者伏立康唑血药浓度相关因素分析

Analysis on relevant factors affecting voriconazole plasma concentration in patients with severe pneumonia

麦瑞珊 1孟冬梅 2谢白露 2肖翔林 2黄思琪 3蔡秀琴 3冯凤玉 3李曜楷 3陈文瑛2

作者信息

  • 1. 510180 广州医科大学附属广州市第一人民医院药剂科
  • 2. 510120 广州医科大学附属第一医院
  • 3. 510182 广州医科大学第一临床学院
  • 折叠

摘要

Abstract

Objective To study the correlation between voriconazole plasma concentration and biochemical indicators as well as concurrent drugs in patients with severe pneumonia.Methods The data of voriconazole plasma concentration,corresponding biomedical indicators,and concurrent quinolone antibacterial,triazole antifungal,hepatoprotective,glucocorticoids drugs use were all recorded in severe pneumonia patients after intravenous injection of voriconazole in our hospital.The relevant factors affecting voriconazole plasma concentration were evaluated with linear regression analysis by SPSS.Results The plasma level of single dose voriconazole was significantly associated with age,alanine aminotransferase,direct bilirubin,gender,body weight adjusted daily dose,proton pump inhibitors,and azithromycin tablets.Conclusion Voriconazole plasma concentration is affected not only by external factors,but also by a number of intrinsic factors as well as the concurrent drugs.

关键词

伏立康唑/血药浓度/生化指标/药物相互作用/重症肺炎

Key words

Voriconazole/ Plasma concentration/ Biochemical indicator/ Drug interactions/ Severe pneumonia

引用本文复制引用

麦瑞珊,孟冬梅,谢白露,肖翔林,黄思琪,蔡秀琴,冯凤玉,李曜楷,陈文瑛..影响重症肺炎患者伏立康唑血药浓度相关因素分析[J].国际医药卫生导报,2013,19(24):3687-3690,4.

基金项目

广州市教育局课题(10A281) (10A281)

国际医药卫生导报

1007-1245

访问量0
|
下载量0
段落导航相关论文